Skip to content

Clinical trials

Terminated Phase 2 Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 2 Status: Terminated Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20092
20101
20112
20123
20133
20161
20171
20192
20201
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
Celgene2
Genfit2
Assistance Publique - Hôpitaux de Paris1
Baylor College of Medicine1
Baylor Research Institute1
Conatus Pharmaceuticals Inc.1
Forest Laboratories1
Intercept Pharmaceuticals1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis22
Idiopathic Pulmonary Fibrosis5
Ascites4
Hypertension, Portal4
Liver Cirrhosis3
Liver Diseases3
Lung Diseases, Interstitial3
Pathologic Processes3
Pulmonary Fibrosis3
Acute-On-Chronic Liver Failure2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.